← Leaderboards
Qianben Wang
Dana-Farber Cancer Inst
$7,988,225
Attributed
$9,633,277
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2007–24$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$18,885,493 · 9
By mechanism
U54$11,439,554 · 2
R01$6,501,807 · 5
R00$764,132 · 1
K99$180,000 · 1
Top collaborators
- Steven K Clinton6 shared
- Jiaoti Huang6 shared
- Tim H.-M. Huang5 shared
- Victor Jin5 shared
- Wei Li1 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Himisha Beltran$8,786,271
- Kenneth L Kehl$1,920,816
- Derin B Keskin$4,214,235
- Ramesh A Shivdasani$32,986,881
- Kunal Rai$10,112,166
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateGene ExpressionTranscription FactorGrowthGenesIn VivoResistanceSamplingTranscriptional RegulationAndrogen ReceptorChromatin ImmunoprecipitationPlayOncogenicProteinsGenetic TranscriptionGenomicsData AnalysesMalignant NeoplasmsCancer CellBaseCellsChromatinMediatingBinding
Grant awards (36)
Elucidating alternative polyadenylation regulation during prostate cancer progression to castration-resistance$690,647
R01 · FY2024 · CA · contact PI
Targeting MED31-driven transcription recycling in lethal prostate cancer$516,712
R01 · FY2024 · CA · contact PI
Targeting MED31-driven transcription recycling in lethal prostate cancer$507,799
R01 · FY2023 · CA · contact PI
Systems Analysis of Epigenomic Architecture in Cancer Progression$1,763,095
U54 · FY2021 · CA
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$413,691
R01 · FY2021 · CA · contact PI
Project 2 Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function$293,849
U54 · FY2021 · CA · contact PI
Systems Analysis of Epigenomic Architecture in Cancer Progression$1,735,899
U54 · FY2020 · CA
Project 2 Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function$433,019
U54 · FY2020 · CA · contact PI
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$383,629
R01 · FY2020 · CA · contact PI
Novel genomic mechanism for ligand-dependent transcription by androgen receptor$305,452
R01 · FY2020 · GM · contact PI
Systems Analysis of Epigenomic Architecture in Cancer Progression$1,729,895
U54 · FY2019 · CA
Project 2 Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function$431,792
U54 · FY2019 · CA · contact PI
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$372,120
R01 · FY2019 · CA · contact PI
Novel genomic mechanism for ligand-dependent transcription by androgen receptor$309,944
R01 · FY2019 · GM · contact PI
Systems Analysis of Epigenomic Architecture in Cancer Progression$2,104,443
U54 · FY2018 · CA
Project 2 Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function$515,602
U54 · FY2018 · CA · contact PI
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$386,836
R01 · FY2018 · CA · contact PI
Novel genomic mechanism for ligand-dependent transcription by androgen receptor$320,681
R01 · FY2018 · GM · contact PI
Systems Analysis of Epigenomic Architecture in Cancer Progression$1,918,884
U54 · FY2017 · CA
Project 2 Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function$513,076
U54 · FY2017 · CA · contact PI
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$340,403
R01 · FY2017 · CA · contact PI
Novel genomic mechanism for ligand-dependent transcription by androgen receptor$245,615
R01 · FY2017 · GM · contact PI
Novel genomic mechanism for ligand-dependent transcription by androgen receptor$82,595
R01 · FY2017 · GM · contact PI
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$52,914
R01 · FY2017 · CA · contact PI
Regulation of androgen receptor function by H3K4 methylation in prostate cancer$317,719
R01 · FY2015 · CA · contact PI
Regulation of androgen receptor function by H3K4 methylation in prostate cancer$308,152
R01 · FY2014 · CA · contact PI
Regulation of androgen receptor function by H3K4 methylation in prostate cancer$298,586
R01 · FY2013 · CA · contact PI
Regulation of androgen receptor function by H3K4 methylation in prostate cancer$317,610
R01 · FY2012 · CA · contact PI
Regulation of androgen receptor function by H3K4 methylation in prostate cancer$330,702
R01 · FY2011 · CA · contact PI
Genome-Wide Analysis of Transcription Factor Function in Prostate Cancer$240,339
R00 · FY2011 · CA · contact PI
Genome-Wide Analysis of Transcription Factor Function in Prostate Cancer$247,808
R00 · FY2010 · CA · contact PI
Genome-Wide Analysis of Transcription Factor Function in Prostate Cancer$247,842
R00 · FY2009 · CA · contact PI
Genome-Wide Analysis of Transcription Factor Function in Prostate Cancer$28,143
R00 · FY2009 · CA · contact PI
Genome-Wide Analysis of Transcription Factor Function in Prostate Cancer$82,878
K99 · FY2008 · CA · contact PI
Genome-Wide Analysis of Transcription Factor Function in Prostate Cancer$7,122
K99 · FY2008 · CA · contact PI
Genome-Wide Analysis of Transcription Factor Function in Prostate Cancer$90,000
K99 · FY2007 · CA · contact PI